FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2893690704> ?p ?o ?g. }

• W2893690704 endingPage "e90" @default.
• W2893690704 startingPage "e81" @default.
• W2893690704 abstract "Background For oligometastatic lung adenocarcinoma patients with sensitive epidermal growth factor receptor (EGFR) mutations, the role of local consolidative therapy (LCT) remains debatable. The purpose of this study was to investigate the efficacy of LCT in oligometastatic lung adenocarcinoma patients. Patients and Methods We conducted a retrospective study to assess the effects of LCT on progression-free survival (PFS) and overall survival (OS). Patients with advanced-stage oligometastatic lung adenocarcinoma harboring sensitive mutation of epidermal growth factor receptor (EGFR) who received EGFR–tyrosine kinase inhibitor (TKI) or EGFR-TKI plus LCT were admitted to Shanghai Chest Hospital from January 2010 to December 2016. The PFS and OS of the 2 groups were accordingly analyzed. Results A total of 231 patients (143 patients who received LCT plus EGFR-TKI [combination group] and 88 patients who only received EGFR-TKI only [monotherapy group]) were included in this study. Median PFS was significantly longer in the combination group (15 months; 95% confidence interval [CI], 13.611-16.389) than in the monotherapy group (10 months; 95% CI, 8.936-11.064; hazard ratio = 0.610; 95% CI, 0.461, 0.807; P = .000). The median OS in the combination group was 34 months (95% CI, 27.889, 40.111) versus 21 months (95% CI, 18.445, 23.555) in the monotherapy group (hazard ratio = 0.593; 95% CI, 0.430-0.817; P = .001). Conclusion LCT combined with TKIs therapy was a feasible method that significantly improved PFS and OS among oligometastatic lung adenocarcinoma patients with EGFR mutations, and it thus might be considered as an important medical treatment during clinical management." @default.
• W2893690704 created "2018-10-05" @default.
• W2893690704 creator A5002725127 @default.
• W2893690704 creator A5011877804 @default.
• W2893690704 creator A5013793018 @default.
• W2893690704 creator A5024307244 @default.
• W2893690704 creator A5036188864 @default.
• W2893690704 creator A5047962353 @default.
• W2893690704 creator A5057723713 @default.
• W2893690704 creator A5058563343 @default.
• W2893690704 creator A5064221485 @default.
• W2893690704 creator A5074659097 @default.
• W2893690704 creator A5082501731 @default.
• W2893690704 creator A5084795769 @default.
• W2893690704 date "2019-01-01" @default.
• W2893690704 modified "2023-10-17" @default.
• W2893690704 title "Efficacy of Local Consolidative Therapy for Oligometastatic Lung Adenocarcinoma Patients Harboring Epidermal Growth Factor Receptor Mutations" @default.
• W2893690704 cites W1969531640 @default.
• W2893690704 cites W1986070056 @default.
• W2893690704 cites W2012295597 @default.
• W2893690704 cites W2038455249 @default.
• W2893690704 cites W2062468238 @default.
• W2893690704 cites W2083992336 @default.
• W2893690704 cites W2103250029 @default.
• W2893690704 cites W2108168221 @default.
• W2893690704 cites W2122476845 @default.
• W2893690704 cites W2124967121 @default.
• W2893690704 cites W2132771960 @default.
• W2893690704 cites W2136601558 @default.
• W2893690704 cites W2142138307 @default.
• W2893690704 cites W2142928555 @default.
• W2893690704 cites W2145754044 @default.
• W2893690704 cites W2150371178 @default.
• W2893690704 cites W2151204647 @default.
• W2893690704 cites W2155338842 @default.
• W2893690704 cites W2192135274 @default.
• W2893690704 cites W2228221433 @default.
• W2893690704 cites W2235523093 @default.
• W2893690704 cites W2272984102 @default.
• W2893690704 cites W2397460919 @default.
• W2893690704 cites W2403758065 @default.
• W2893690704 cites W2536769127 @default.
• W2893690704 cites W2559141477 @default.
• W2893690704 cites W2585587591 @default.
• W2893690704 cites W2739010860 @default.
• W2893690704 cites W2782802567 @default.
• W2893690704 cites W2917837889 @default.
• W2893690704 cites W4231096603 @default.
• W2893690704 cites W4240340450 @default.
• W2893690704 cites W4297928880 @default.
• W2893690704 doi "https://doi.org/10.1016/j.cllc.2018.09.010" @default.
• W2893690704 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30341018" @default.
• W2893690704 hasPublicationYear "2019" @default.
• W2893690704 type Work @default.
• W2893690704 sameAs 2893690704 @default.
• W2893690704 citedByCount "38" @default.
• W2893690704 countsByYear W28936907042019 @default.
• W2893690704 countsByYear W28936907042020 @default.
• W2893690704 countsByYear W28936907042021 @default.
• W2893690704 countsByYear W28936907042022 @default.
• W2893690704 countsByYear W28936907042023 @default.
• W2893690704 crossrefType "journal-article" @default.
• W2893690704 hasAuthorship W2893690704A5002725127 @default.
• W2893690704 hasAuthorship W2893690704A5011877804 @default.
• W2893690704 hasAuthorship W2893690704A5013793018 @default.
• W2893690704 hasAuthorship W2893690704A5024307244 @default.
• W2893690704 hasAuthorship W2893690704A5036188864 @default.
• W2893690704 hasAuthorship W2893690704A5047962353 @default.
• W2893690704 hasAuthorship W2893690704A5057723713 @default.
• W2893690704 hasAuthorship W2893690704A5058563343 @default.
• W2893690704 hasAuthorship W2893690704A5064221485 @default.
• W2893690704 hasAuthorship W2893690704A5074659097 @default.
• W2893690704 hasAuthorship W2893690704A5082501731 @default.
• W2893690704 hasAuthorship W2893690704A5084795769 @default.
• W2893690704 hasConcept C121608353 @default.
• W2893690704 hasConcept C126322002 @default.
• W2893690704 hasConcept C143998085 @default.
• W2893690704 hasConcept C167135981 @default.
• W2893690704 hasConcept C207103383 @default.
• W2893690704 hasConcept C2776256026 @default.
• W2893690704 hasConcept C2776999253 @default.
• W2893690704 hasConcept C2777714996 @default.
• W2893690704 hasConcept C2779438470 @default.
• W2893690704 hasConcept C2780580887 @default.
• W2893690704 hasConcept C2781182431 @default.
• W2893690704 hasConcept C44249647 @default.
• W2893690704 hasConcept C71924100 @default.
• W2893690704 hasConceptScore W2893690704C121608353 @default.
• W2893690704 hasConceptScore W2893690704C126322002 @default.
• W2893690704 hasConceptScore W2893690704C143998085 @default.
• W2893690704 hasConceptScore W2893690704C167135981 @default.
• W2893690704 hasConceptScore W2893690704C207103383 @default.
• W2893690704 hasConceptScore W2893690704C2776256026 @default.
• W2893690704 hasConceptScore W2893690704C2776999253 @default.
• W2893690704 hasConceptScore W2893690704C2777714996 @default.
• W2893690704 hasConceptScore W2893690704C2779438470 @default.
• W2893690704 hasConceptScore W2893690704C2780580887 @default.
• W2893690704 hasConceptScore W2893690704C2781182431 @default.

• next